Treatment of Refractory Antibody-mediated Rejection with Bortezomib in a Kidney Transplant Recipient: A Case Report-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Treatment of Refractory Antibody-mediated Rejection with Bortezomib in a Kidney Transplant Recipient: A Case Report

Published:2014 Issue:2 Volume:28 Page:87
ISSN:1598-1711
Container-title:The Journal of the Korean Society for Transplantation
language:ko
Short-container-title:J Korean Soc Transplant

Author:

Lee Ji Yeon¹,Yoo Jin Young¹,Kwon Soon Hyo¹,Jeon Jin Seok¹,Noh Hyunjin¹,Han Dong Cheol¹,Song Dan²,Jin So Young³

Affiliation:

1. Department of Internal Medicine, Soonchunhyang University Hospital, Soonchunhyang University College of Medicine, Seoul, Korea.

2. Department of Surgery, Soonchunhyang University Hospital, Soonchunhyang University College of Medicine, Seoul, Korea.

3. Department of Pathology, Soonchunhyang University Hospital, Soonchunhyang University College of Medicine, Seoul, Korea.

Publisher

The Korean Society for Transplantation

Link

https://synapse.koreamed.org/pdf/10.4285/jkstn.2014.28.2.87

Reference18 articles.

1. Proteasome inhibition with bortezomib: an effective therapy for severe antibody mediated rejection after renal transplantation

2. Use of bortezomib to treat anti-HLA antibodies in renal transplant patients: A single-center experience

3. The Role of Proteasome Inhibition With Bortezomib in the Treatment of Antibody-Mediated Rejection After Kidney-Only or Kidney-Combined Organ Transplantation

4. Proteasome inhibition by bortezomib: Effect on HLA-antibody levels and specificity in sensitized patients awaiting renal allograft transplantation

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP